Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $56,926 | 3 | 62.1% |
| Consulting Fee | $30,771 | 8 | 33.5% |
| Travel and Lodging | $2,317 | 12 | 2.5% |
| Food and Beverage | $1,725 | 25 | 1.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ichnos Sciences Inc. | $56,926 | 3 | $0 (2020) |
| Celgene Corporation | $19,508 | 17 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $7,447 | 14 | $0 (2024) |
| Legend Biotech USA Inc. | $4,109 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $3,229 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $173.19 | 2 | $0 (2024) |
| PFIZER INC. | $127.82 | 1 | $0 (2017) |
| DePuy Synthes Sales Inc. | $112.49 | 2 | $0 (2024) |
| Kite Pharma, Inc. | $52.82 | 1 | $0 (2019) |
| Janssen Research & Development, LLC | $28.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $266.46 | 3 | E.R. Squibb & Sons, L.L.C. ($173.52) |
| 2023 | $8,640 | 17 | Legend Biotech USA Inc. ($4,109) |
| 2022 | $6,297 | 3 | E.R. Squibb & Sons, L.L.C. ($6,228) |
| 2021 | $5,893 | 2 | Novartis Pharmaceuticals Corporation ($3,125) |
| 2020 | $68,194 | 6 | Ichnos Sciences Inc. ($56,926) |
| 2019 | $309.92 | 4 | Janssen Biotech, Inc. ($124.00) |
| 2018 | $1,983 | 11 | Celgene Corporation ($1,983) |
| 2017 | $156.74 | 2 | PFIZER INC. ($127.82) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | DePuy Synthes Sales Inc. | — | Food and Beverage | In-kind items and services | $43.75 | General |
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Food and Beverage | Cash or cash equivalent | $173.52 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | AXERT (Drug) | Food and Beverage | In-kind items and services | $49.19 | General |
| Category: Neuroscience | ||||||
| 12/27/2023 | Legend Biotech USA Inc. | — | Consulting Fee | Cash or cash equivalent | $3,940.00 | General |
| 12/12/2023 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $3,460.00 | General |
| 12/08/2023 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $94.28 | General |
| 12/08/2023 | Legend Biotech USA Inc. | — | Travel and Lodging | Cash or cash equivalent | $47.14 | General |
| 12/08/2023 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $27.69 | General |
| 09/28/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $324.66 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $308.04 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $129.23 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $51.14 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $49.75 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.00 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.62 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| 09/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| 05/09/2023 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 10/23/2022 | DePuy Synthes Sales Inc. | ATTUNE (Device) | Food and Beverage | In-kind items and services | $68.74 | General |
| Category: Ortho-Knee | ||||||
| 09/20/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,384.00 | General |
| 02/10/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,844.00 | General |
| 08/07/2021 | Celgene Corporation | ABECMA (Biological) | Consulting Fee | Cash or cash equivalent | $2,768.00 | General |
| Category: Oncology | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ISB 1342-101 | Ichnos Sciences Inc. | $56,926 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 40 | $11,153 | $2,499 |
| 2022 | 1 | 23 | 131 | $52,269 | $11,517 |
| 2020 | 2 | 29 | 57 | $28,640 | $4,897 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 29 | $8,062 | $1,809 | 22.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $3,091 | $690.50 | 22.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 131 | $52,269 | $11,517 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 40 | $19,800 | $3,811 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 17 | $8,840 | $1,086 | 12.3% |
About Eric Smith, MD, PHD
Eric Smith, MD, PHD is a Medical Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1710202866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Smith, MD, PHD has received a total of $91,740 in payments from pharmaceutical and medical device companies, with $266.46 received in 2024. These payments were reported across 48 transactions from 11 companies. The most common payment nature is "" ($56,926).
As a Medicare-enrolled provider, Smith has provided services to 79 Medicare beneficiaries, totaling 228 services with total Medicare billing of $18,913. Data is available for 3 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Boston, MA
- Active Since 04/01/2010
- Last Updated 10/26/2022
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1710202866
Products in Payments
- ISB 1342-101 (Drug) $56,926
- ABECMA (Biological) $2,942
- Revlimid (Drug) $153.49
- DARZALEX (Biological) $152.92
- KYMRIAH (Biological) $103.77
- ATTUNE (Device) $68.74
- Yescarta (Drug) $52.82
- AXERT (Drug) $49.19
- CAR-T (Drug) $29.33
- ZYNRELEF (Drug) $25.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Boston
Dr. George Demetri, Md, MD
Medical Oncology — Payments: $1.6M
Pasi Antero Janne, Md Phd, MD PHD
Medical Oncology — Payments: $1.1M
Dr. Praful Ravi, Mb Bchir, MB BCHIR
Medical Oncology — Payments: $921,658
Dr. Alicia Morgans, Md, MD
Medical Oncology — Payments: $755,277
Dr. Erica Mayer, Md Mph, MD MPH
Medical Oncology — Payments: $665,160
Dr. Joaquin Bellmunt Molins, M.d, M.D
Medical Oncology — Payments: $610,701